Yano O, Kanellopoulos J, Kieran M, Le Bail O, Israël A, Kourilsky P
Unité de Biologie Moléculaire du Gène, Institut National de la Santé et de la Recherche Médicale, Institut Pasteur, Paris, France.
EMBO J. 1987 Nov;6(11):3317-24. doi: 10.1002/j.1460-2075.1987.tb02652.x.
An enhancer binding factor, designated KBF1, has been purified from the nuclear extract of mouse BW5147 thymoma cells by five column chromatography steps including a sequence-specific DNA affinity column. Gel retardation and footprint analysis have shown that purified KBF1 has a binding activity specific for both H-2 and beta 2-microglobulin enhancer sequences. After SDS-polyacrylamide gel electrophoresis of the most purified preparation a 48-kd protein showed, after elution and renaturation, a binding activity to both enhancer sequences. These findings suggest that the expression of both H-2 and beta 2-microglobulin genes utilizes a common regulatory mechanism.
一种名为KBF1的增强子结合因子,已通过包括序列特异性DNA亲和柱在内的五步柱层析法,从小鼠BW5147胸腺瘤细胞的核提取物中纯化出来。凝胶阻滞和足迹分析表明,纯化后的KBF1对H-2和β2-微球蛋白增强子序列均具有特异性结合活性。对最纯的制剂进行SDS-聚丙烯酰胺凝胶电泳后,一种48-kd的蛋白质经洗脱和复性后,对两种增强子序列均显示出结合活性。这些发现表明,H-2和β2-微球蛋白基因的表达利用了一种共同的调控机制。